Caracterización de eventos de hipoglicemia en pacientes diabéticos y no diabéticos atendidos en un servicio de urgencia
Author
dc.contributor.author
Vargas Reyes, Regina Cecilia
Author
dc.contributor.author
San Cristóbal, Fernando
Author
dc.contributor.author
Jara, Paula
Author
dc.contributor.author
López, Sebastián
Author
dc.contributor.author
Trujillo, Juan
Admission date
dc.date.accessioned
2018-05-14T16:49:56Z
Available date
dc.date.available
2018-05-14T16:49:56Z
Publication date
dc.date.issued
2017
Cita de ítem
dc.identifier.citation
Rev Med Chile 2017; 145: 1387-1393
es_ES
Identifier
dc.identifier.issn
0717-6163
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/147697
Abstract
dc.description.abstract
Background: Hypoglycemia is the main limitation for the achievement
of glycemic goals in the treatment of diabetes. Aim: To assess the incidence of
hypoglycemia in an emergency department. To characterize and identify which
patients are at higher risk of having it. Material and Methods: We reviewed
the electronic records of patients discharged from an adult emergency room with
the diagnosis of hypoglycemia between May 2011 and December 2014. Age,
sex, diagnosis of diabetes (DM), antidiabetic therapy, glycosylated hemoglobin,
creatinine, destination at time of discharge, blood glucose, impairment of
conscience, treatment of the event and predictions were recorded. Results: Of
175,244 attentions analyzed, 251 in patients aged 69 ± 17 years (54% women)
consulted for hypoglycemia (0.14%). Eighty one percent had a type 2 diabetes,
6% a type 1 diabetes and 12% were non-diabetic. Mean blood glucose was
44.1 mg/dl. In diabetic patients, mean glycosylated hemoglobin was 6.5%.
Ninety seven percent had impairment of conscience and 77% were admitted to
the hospital. Among patients without diabetes, the main comorbidity was the
history of a gastric bypass surgery. In type 2 diabetes, glibenclamide used alone or
with other medications was involved in 59% of the events, 87% of patients were
older than 65 years with a mean glycosylated hemoglobin of 6.3% and 32% had
renal failure. Conclusions: The incidence of hypoglycemia was low. There were
a significant number of events in older patients with type 2 diabetes mellitus and
renal failure, who were treated with glibenclamide. Most of these patients had a
glycosylated hemoglobin below accepted recommendations.